© 2019 IPHARMA

  • Facebook Social Icon
  • LinkedIn Social Icon
  • YouTube Social  Icon
  • Instagram Social Icon


On June 2, ASCO Annual Meeting 2017, the main event of the year for specialists in the field of oncology, had started.
Annually in Chicago, USA, more than 30,000 medical and pharmaceutical workers gather to discuss modern methods of treatment and i...


On May 5th, 2016, IPHARMA was authorized by the Ministry of Healthcare of the Russian Federation to conduct the Phase II clinical study of the medicinal product Quisinostat.

Protocol № ONC-14-NSCLCII-1-1QUI-3 "Multicenter double-blind randomized place...

Please reload

Please reload

Поиск по тегам